AutoGenomics Sets Price Range for Planned IPO, Anticipates up to $46.6M in Proceeds | GenomeWeb

NEW YORK (GenomeWeb) – AutoGenomics on Monday priced its planned initial public offering at between $11 and $13 per share, with anticipated net proceeds of up to $46.6 million. 

In an amended prospectus, the company said it plans to offer 3.75 million shares of its common stock in its IPO. It plans to list its shares on the Nasdaq Global Market under ticker symbol "AGMX." 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.